Pharmaceutical Affairs Act Article 93

Any person who violates any of the provisions of Paragraph 2 of Article 16, Article 28, Article 30, the first paragraph of Article 32, Article 33, the first paragraph of Article 37, Article 38, or Article 62 or falls under the following conditions, shall be imposed with a fine of not less than NT$30,000 but not more than NT$5,000,000:1. Where the manufacturing, labeling, or sale of general sale medicines and pharmaceutical preparations of inherited formulations violate the provisions under Paragraph 3 of Article 8 established by the central competent health authority.2. Where the classification and supervision of medical devices violate the provisions under Paragraph 2 of Article 13 established by the central competent health authority.3. Where the use or packaging of medicament samples or gifts violates the provisions under Paragraph 2 of Article 55 established by the central competent health authority.In addition to the imposition of a fine pursuant to the provision of the preceding paragraph, the competent health authority may also suspend the business operations of the violator if he/she violates the provisions of Paragraph 2 of Article 16 or Article 30.
中文原文 藥事法第93條
違反第十六條第二項、第二十八條、第三十條、第三十二條第一項、第三十三條、第三十七條第一項、第三十八條或第六十二條規定之一,或有左列情形之一者,處新臺幣三萬元以上五百萬元以下罰鍰:
一、成藥、固有成方製劑之製造、標示及販售違反中央衛生主管機關依第八條第三項規定所定辦法。
二、醫療器材之分級及管理違反中央衛生主管機關依第十三條第二項規定所定辦法。
三、藥物樣品、贈品之使用及包裝違反中央衛生主管機關依第五十五條第二項規定所定辦法。
違反第十六條第二項或第三十條規定者,除依前項規定處罰外,衛生主管機關並得停止其營業。

English translation for reference only; the Chinese text prevails. Not legal advice.